Company / Net Income
Arbutus Biopharma Corp Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$33.5M
FY2025
5-year range
-$76.2M / -$33.5M
FY2021-FY2025
Trend
+52.1%
vs FY2024
Sector context
#77 of 216
Health Care
What the data says
At -$34M, Arbutus Biopharma Corp's net income ranks #77 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$384M in FY2016 to -$24M in FY2019.
Based on SEC 10-K filings.
-$34M in FY2025.
Improved from -$73M to -$34M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 216 in Health CareTop 36% of 216This company -$33.5M Sector average $454.3M
▼
-107.4% below sector average
Key checks
Key Insights
- In FY2025, net income increased 52.1% year-over-year.
- Ranks #77 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$33.5M | +52.1% |
| FY2024 | -$69.9M | +4.0% |
| FY2023 | -$72.8M | -4.9% |
| FY2022 | -$69.5M | +8.9% |
| FY2021 | -$76.2M | +50.4% |
| FY2020 | -$153.7M | -528.1% |
| FY2019 | -$24.5M | +71.0% |
| FY2018 | -$84.4M | +0.0% |
| FY2017 | -$84.4M | +78.0% |
| FY2016 | -$384.2M | -512.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026